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The differentiation, survival, and proliferation of developing sympathetic neuroblasts are all coordinately promoted by
neurotrophins. In this study, we demonstrate that bone morphogenetic protein 4 (BMP4), a factor known to be necessary for
the differentiation of sympathetic neurons (Schneider et al., 1999), conversely reduces both survival and proliferation of
cultured E14 sympathetic neuroblasts. The anti-proliferative effects of BMP4 occur more rapidly than the pro-apoptotic
actions and appear to involve different intracellular mechanisms. BMP4 treatment induces expression of the transcription
factor Msx-2 and the cyclin-dependent kinase inhibitor p21CIP1/WAF1 (p21). Treatment of cells with oligonucleotides antisense
to either of these genes prevents cell death after BMP4 treatment but does not significantly alter the anti-proliferative
effects. Thus Msx-2 and p21 are necessary for BMP4-mediated cell death but not for promotion of exit from cell cycle.
Although treatment of cultured E14 sympathetic neuroblasts with neurotrophins alone did not alter cell numbers,
BMP4-induced cell death was prevented by co-treatment with either neurotrophin-3 (NT-3) or nerve growth factor (NGF).
This suggests that BMP4 may also induce dependence of the cells on neurotrophins for survival. Thus, sympathetic neuron
numbers may be determined in part by factors that inhibit the proliferation and survival of neuroblasts and make them
dependent upon exogenous factors for survival. © 2001 Academic Press
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Differentiation of neural crest cells (NCC) into sympa-
thetic neuroblasts is influenced by signals that mitotic
NCC encounter along their migratory pathways (for review,
see Francis and Landis, 1999). Sympathetic neuroblasts
remain mitotic even after they aggregate into discrete
ganglia (Rubin, 1985), and they survive and proliferate in
culture in the absence of neurotrophins or growth factors
(Coughlin, and Collins, 1985; Ernsberger et al., 1989; Birren
et al., 1993; DiCicco-Bloom et al., 1993, 2000). However,
heir proliferation may be stimulated by a number of factors
ncluding insulin, insulin-like growth factor (IGF), and the
europeptide pituitary adenylate cyclase-activating
olypeptide (PACAP) (DiCCicco-Bloom and Black, 1988,
989; DiCicco-Bloom et al., 2000), and survival in culture is
1 To whom correspondence should be addressed. Fax: 312-503-
0872. E-mail: jakessler@northwestern.edu.
212nhanced by neurotrophin 3 (NT3) (DiCicco-Bloom et al.,
993). Following the end of cell division, sympathetic
eurons become dependent on neurotrophins and other
rophic factors for survival, and the number of neurons that
urvive in the adult animal is limited by the availability of
eurotrophins produced by target tissues (for review, see
nider, 1994). The mechanisms that govern the loss of
roliferative capacity and the concomitant acquisition of
eurotrophin dependence by sympathetic neuroblasts re-
ain unclear.
Several lines of evidence suggest that these processes
ight be regulated by members of the bone morphogenetic
rotein (BMP) family of the TGF-b superfamily. BMPs have
been implicated in the induction of neural crest (Liem et al.,
1995) and the commitment of NCC to the neuronal pheno-
type (Shah et al., 1999), and BMPs are required for the
generation of sympathetic neurons in vivo (Schneider et al.,
1999). Embryonic ganglia throughout the peripheral ner-
vous system (PNS) express BMP receptors (Zhang et al.,
0012-1606/01 $35.00
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213BMP4 Regulation of Sympathetic Neuron Numbers1998), indicating the potential for BMP sensitivity, and
BMPs are expressed in embryonic ganglia and surrounding
tissues (Shah et al., 1996). Further, BMP treatment of
ultured sympathetic neurons induces expression of trkC
Zhang et al., 1998), indicating that sympathetic neurons
re BMP-responsive. BMPs limit population size of a num-
er of embryonic cell types including neocortical ventricu-
ar zone cells (Furuta et al., 1997; Mabie et al., 1999) both by
romoting exit from cell cycle and by inducing apoptosis
Mabie et al., 1999). Moreover, BMP treatment of MAH
ells, a sympathoadrenal cell line (Vandenbergh et al.,
991), promotes exit from cell cycle and induces apoptosis
nd neurotrophin dependence (Song et al., 1998). Since
hese cells resemble sympathetic neuroblasts, we hypoth-
sized that bone morphogenetic proteins (BMPs) might
erve as a signal that halts proliferation and initiates growth
actor dependence of sympathetic neurons. We sought,
herefore, to directly determine the effects of BMP4 on
roliferation and survival of cultured sympathetic neuro-
lasts. In addition, we examined the role in neuroblast
esponses to BMP4 of two target genes potentially involved
n pro-apoptotic effects of BMPs, the transcription factor
sx-2 (Graham et al., 1994; Marazzi et al., 1997) and the
yclin-dependent kinase inhibitor p21 (Jernvall et al., 1998).
e find that BMP treatment of cultured sympathetic neu-
oblasts promotes exit from cell cycle, and that the cells
ecome dependent upon the presence of neurotrophins for
urvival. BMP induction of Msx-2 and p21 expression is
ssential for the effects of the factor on survival but not for
he promotion of exit from cell cycle.
MATERIALS AND METHODS
Animals
Timed-pregnant embryonic Sprague/Dawley rats were pur-
chased from Taconic Farms (German Town, NY). Mice heterozy-
gous for a Bax deletion allele were the kind gift of S. Korsmeyer.
Ganglia from each mouse embryo were cultured in separate dishes.
Embryo genotypes were then determined by using a PCR-based
assay as described by Deckwerth (1996).
Culture of Sympathetic Neuroblasts
Superior cervical ganglia (SCG) were removed from embryonic
day-14 (E14) rat embryos, enzymatically (trypsin 0.1%) and me-
chanically dissociated, and plated in a defined medium on poly-D-
ysine-coated 35-mm culture dishes at a density of about 40,000
ells per dish. The culture medium consisted of a 50/50 mixture of
am’s F12 and Dulbecco’s modified Eagle’s medium containing
ransferrin (50 mg/ml), putrescine (100 mM), progesterone (20 nM),
selenium (30 nM), glutamine (2 mM), insulin (10 mg/ml), and
penicillin-streptomycin (50 U/ml). Cells were maintained at 37°C
in a humidified atmosphere containing 5% CO2. In some cultures,
recombinant human BMP4 (Genetics Institute, Cambridge, MA)
was added at a concentration of 10 ng/ml, and in others recombi-
nant human NT3 or NGF (Genentech Inc., South San Francisco,
CA) was added at 25 ng/ml. For washout experiments, neuroblasts
were initially cultured in medium containing BMP4 (10 ng/ml) or
Copyright © 2001 by Academic Press. All rightNT3 (25 ng/ml). After 2–18 h, the medium was removed, the
cultures were washed with control medium, and incubation was
continued in control medium or medium containing NT3 (25
ng/ml).
Oligonucleotides
Antisense, sense, or scrambled (same G/C ratio) phosphorothioate-
protected oligonucleotides were coupled to Penetratin 1 (Oncor,
Gaithersburg, MD), a peptide that facilitates movement of oligonu-
ceotides across cell membranes. Briefly, the oligonucleotides were
resuspended in deionized water, an equimolar ratio of Penetratin 1
was added, and the mixture was incubated at 37°C for 1 h to allow
coupling. Cultures were treated with 400 nM Penetratin-coupled
oligonucleotides unless otherwise stated. The p21 antisense oligonu-
cleotide was designed around the start codon of the rat p21 sequence:
59-GAC ATC ACC AGG ATC GGA CAT-39. The sense p21 sequence
was 59-ATG TCC GAT CCT GGT GAT GTC-39. The Msx2 antisense
oligonucleotide was also designed to include the ATG initiation site:
59-GCC TTT AGT CGG AGA AGC CAT-39 and the sense sequence
was 59-ATG GCT TCT CCG ACT AAA GGC-39.
BrdU Incorporation Assay
To label cells in the S-phase of the cell cycle, BrdU (10 mM)
Boehringer-Mannheim) was added to the culture medium for 6 h
or 8 h in some experiments when noted) prior to examination. The
edium was then removed and the cells were washed in PBS. The
ells were then fixed in 100% ice-cold methanol for 15 min,
rogressively rehydrated in PBS, incubated in 2 M HCl for 45 min
t room temperature to denature the DNA, again washed in PBS,
eutralized with 0.1 M Na2B4O7 (pH 8.5) for 15 min, and washed in
PBS. Cellular preparations were incubated with anti-BrdU antibody
(1:400; Vector Laboratories, Burlingame, CA) with 5% goat serum
overnight at 4°C, washed, and incubated with FITC-conjugated
secondary antibody (1:200; Southern Biotechnologies) for 1 h at
room temperature. After washing twice in PBS, coverslips were
counterstained with Hoechst 33342 (2 mg/ml, Molecular Probes) to
visualize nuclei and to determine total cell numbers. After washing
twice with water, coverslips were mounted by using anti-fade
reagent (Molecular Probes), and photographed with an Olympus
BX50 epifluorescence microscope for cell counting.
Determination of Viability of Cells
The numbers of viable and nonviable cells were determined by
trypan blue exclusion. In most experiments, the cells were also
assessed morphologically. Nonviable cells consistently exhibited
loss of cell membrane integrity and/or shrinkage of the soma to less
than 50% of the size of average cells in the same dish, and
increasing condensation and cleavage of the nucleus. Morphologic
assessment, using an intact cell membrane and the absence of
significant cell shrinkage under 203 phase microscopy as criteria
for viability, agreed with the data using trypan blue exclusion to
within 3–4% in all experiments. Data reported using trypan blue
exclusion are the means 6 SEM of least three separate culture
experiments.
Nuclease Protection Assays
Antisense riboprobes for Msx-2 and p21 were generated in 25 ml
of buffer containing: 200 mM Tris–Cl, pH 7.5, 30 mM MgCl, 10
s of reproduction in any form reserved.
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214 Gomes and KesslermM spermidine, 50 mM NaCl, 0.4 mM ATP, 0.4 mM GTP, 0.4 mM
CTP, 10 ml of [a-32P]UTP, 800 Ci/mmol, 20 mM DTT, 20 units of
lacental ribonuclease inhibitor, 0.5 mg of template DNA, and 20
nits of T7 or SP6 RNA polymerase. The mixture was incubated at
0°C for SP6 or at 37°C for T7 for 60 min. Probes were purified by
el filtration. Total RNA from cultures of sympathetic neuroblasts
10 mg) was hybridized with 5 3 105cpm of RNA probes at 60°C
vernight. The mixture was digested with 40 mg/ml ribonuclease A
and 2 mg/ml ribonuclease T1. Hybridized RNAs were electropho-
esed on 5% polyacrymide gels and visualized by autoradiography.
Statistics
All data are presented as the mean 6 SEM of at least three
replicate samples, and the results of each experimental condition
were verified a minimum of three times. Significance was deter-
mined by one-way ANOVA with Bonferroni post hoc analysis or by
Student’s t-test when applicable.
RESULTS
Viability and rates of proliferation of cells cultured from
embryonic day-14 (E14), E15, and E15.5 superior cervical
ganglia (SCG) were assessed in a defined medium with and
without the presence of insulin. In the presence of insulin,
78% of cells plated from E14 ganglia survived for 24 h
whereas only 66% of cells from E15 ganglia and 54% of
cells from E15.5 ganglia survived (Fig. 1). In the absence of
insulin, rates of survival were 72, 59, and 42%, respectively,
FIG. 1. Survival and proliferation of cells from E14, E15, and
E15.5 SCG cultured in the presence or absence of insulin (10
mg/ml). BrdU was added after 16 h in culture, and survival and
proliferation were determined at 24 h. Note that insulin signifi-
cantly increased survival only of E15.5 cells but significantly
increased proliferation at all ages. p, Differs from age-matched
cultures containing insulin at P , 0.05; pp, Differs from age-
atched cultures containing insulin at P , 0.02from E14, E15, and E15.5 ganglia. Thus, insulin exerted a
Copyright © 2001 by Academic Press. All rightmall effect on cell survival that was significant at E15.5. In
he presence of insulin, 78, 61, and 57% of cells incorpo-
ated BrdU, respectively, from E14, E15, and E15.5 ganglia
Fig. 1). By contrast, in the absence of insulin only 46, 39,
nd 33% of cells incorporated BrdU from E14, E15, and
15.5 ganglia, respectively. Thus, insulin significantly
timulated proliferation of cells from all three ages. In
reliminary experiments, BMP4 was noted to reduce sur-
ival and proliferation of cells. To facilitate study of the
ctions of BMP4, cells in all subsequent experiments were
ultured in the presence of insulin to maximize prolifera-
ion in control conditions.
To define the cellular phenotype of cells cultured from
14 ganglia, tyrosine hydroxylase immunoreactivity was
xamined after 24 h in vitro in the absence or presence of
MP4. Ninety-eight percent of control cells and 96% of
MP-treated cells expressed TH immunoreactivity, indicat-
ng that virtually all of the cells were sympathetic neuro-
lasts or neurons. Similar proportions of cells expressed
eurofilament (NF160) immunoreactivity.
Effects of BMP4 on Survival and Proliferation
To examine the effects of BMP4 on survival and prolif-
eration of E14 sympathetic neuroblasts, BMP4 (10 ng/ml) or
buffer was added to cultures 30 min after plating, and cell
viability was assessed by dye exclusion after 24 h (Fig. 2A).
BrdU was added to some cultures for the final 6 h of the
culture period to quantitate proliferation. In the absence of
BMP4, cell numbers increased by 46% after 24 h in culture.
Eighty-one percent of the cells were viable and 41% of total
cells incorporated BrdU (Fig. 2A). By contrast, cell numbers
were significantly reduced by more than 70% after BMP4
treatment. Cell survival was markedly reduced with only
32% viability at 24 h. Proliferation was also significantly
reduced with only 4% of neuroblasts BrdU-positive. We
determined the dose-response relationship for BMP4 by
culturing neuroblasts in 0.01–100 ng/ml BMP4 and assess-
ing survival after 24 h (Fig. 2B). Half-maximal effects were
achieved at 1 ng/ml and maximum inhibition of survival
was evident at 10 ng/ml.
Time Course of BMP4 Effects on Survival and
Proliferation
Although these experiments suggested independent ef-
fects of BMP4 on both proliferation and survival, it was
possible that BMP4 preferentially killed rapidly dividing
neuroblasts leading to a secondary reduction in prolifera-
tion. To help distinguish between these two possibilities,
we compared the time course of BMP4 effects on prolifera-
tion and survival. Cell viability in control medium was
88% after 6 h and did not decrease significantly after 12 or
24 h (Fig. 3A). In cells treated with BMP4, viability was
indistinguishable from control at 6 and 12 h, but dimin-
ished to 31% after 24 h. These results suggest that cell
death only occurs after more than 12 h of BMP4 exposure.
s of reproduction in any form reserved.
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215BMP4 Regulation of Sympathetic Neuron NumbersBy contrast, reductions in BrdU incorporation occurred
more rapidly (Fig. 3B). In untreated cultures, 15% of neuro-
blasts incorporated BrdU after 6 h, and the percent of
labeled cells increased to 53% at 12 h and 79% at 24 h.
BMP4-treated cultures examined at 6 h exhibited 27% BrdU
labeling, a small but statistically significant increase com-
pared to control. However, by 12 h, BrdU labeling was
significantly reduced to less than 20%, of cells, and incor-
poration remained at this low level at 24 h. Thus, after a
small, transient increase in BrdU labeling, incorporation
was already significantly reduced at 12 h before any change
in viability was detected. These results suggest that BMP4
exerts a direct anti-mitotic influence on cultured sympa-
thetic neuroblasts, and that the reduced proliferation ob-
served in BMP4-treated cultures is not due to preferential
FIG. 2. BMP4 inhibits proliferation and reduces survival of cul-
tured sympathetic neuroblasts. (A) Neuroblasts were cultured with
or without BMP4 (10 ng/ml). BrdU was added to some cultures after
18 h in vitro, and cell viability and BrdU incorporation were
assessed after 24 h. Note that BMP4 treatment causes significant
declines in both proliferation and survival. p, Differs from control
at P , 0.01. (B) Inhibition of BMP4 is dose-dependent. Neuroblasts
were cultured in 0.1–100 ng/ml BMP4 and survival was assessed
after 24 h in culture.loss of rapidly dividing cells.
Copyright © 2001 by Academic Press. All rightIn the preceding experiments, BMP4 was present in the
ulture medium throughout the culture period. It was
herefore unclear when BMP4-induced death became irre-
ersible. To address this question, we cultured neuroblasts
n medium containing 10 ng/ml BMP4 for 2–18 h, ex-
hanged the culture medium with control medium to
emove BMP4, and analyzed cell viability 24 h after the
nitial addition of BMP4. BMP4 exposure for the first 8 h of
ulture resulted in a statistically significant 29% decline in
iability (Fig. 3C). The decline increased to 47% with 12 h
f exposure and was maximal (55% decrease) after 18 h.
herefore, BMP4 was not continually required in the cul-
ure medium for cell death to occur. Instead, neuroblasts
ecome committed to a cell-death program that proceeds
ven after removal of BMP4. Note that washout of BMP4 at
or 4 h successfully prevented significant cell death com-
ared with control, suggesting that our washout protocol
ffectively removed BMP4 from the culture environment.
Effects of BMP4 on Expression of Msx-2 and p21
To more clearly determine whether effects of BMP4 on
proliferation and survival reflect independent and separable
actions of the factor, we sought to define the underlying
intracellular mechanisms. Effects of BMP4 on the expres-
sion of two potential target genes, the transcription factor
Msx-2 (Graham et al., 1994; Marazzi et al., 1997) and the
yclin-dependent kinase inhibitor p21 (Jernvall et al., 1998),
ere therefore examined. Control sympathetic neuroblasts
id not express detectable levels of either Msx-2 or p21
RNA after 6 or 12 h in culture (Fig. 4). By contrast, cells
reated with BMP4 expressed both Msx-2 and p21 mRNAs
t 6 and 12 h.
Effects of Antisense Oligonucleotides on Expression
of Msx-2 and p21
To examine the functional roles of Msx-2 and p21 in
BMP4 effects on sympathetic neuroblasts, we sought to
determine whether the BMP4-mediated increases in Msx-2
and p21 could be inhibited with antisense oligonucleotides.
Addition of oligonucleotides antisense to Msx-2 or p21
prevented increases in the expression of their respective
mRNAs after BMP4 treatment (Fig. 4). By contrast, treat-
ment with sense oligonucleotides (Fig. 4) or scrambled
oligonucleotides (data not shown) did not affect the BMP4-
mediated increases in the mRNAs.
Role of Msx-2 and p21 in the Pro-Apoptotic and
Anti-Mitotic Effects of BMP4
The antisense oligonucleotides were then used to deter-
mine whether Msx-2 and p21 induction are required for the
pro-apoptotic and anti-mitotic responses of sympathetic
neuroblasts to BMP4. Treatment of BMP4-containing cul-
tures with the Msx-2 antisense oligonucleotide blocked the
decline in viability seen with BMP4 alone (Fig. 5A). The
s of reproduction in any form reserved.
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Copyright © 2001 by Academic Press. All rightanti-mitotic effects of BMP4, in contrast, were unaffected
by reduced Msx-2 expression (Fig. 5B). Sense Msx-2 oligo-
nucleotide (Fig. 5) or scrambled oligonucleotide did not
alter basal or BMP4-treated viability or proliferation. These
results suggest that induction of Msx-2 is required for
BMP4-mediated cell death, but not for BMP4-mediated
inhibition of proliferation. We also tested the requirement
for p21 induction in BMP4-induced responses. Similar to
Msx-2, antisense inhibition of p21 expression protected
neuroblasts from BMP4-induced cell death (Fig. 6) but did
not significantly affect the inhibition of proliferation by
BMP4, although there was a trend towards increased prolif-
eration after treatment with antisense p21. Treatment with
sense p21 oligonucleotides (Fig. 6) or scrambled oligonucle-
otides was without effect.
neuroblast proliferation by 12 h of culture. p, Differs from control
at P , 0.05. pp, Differs from control at P , 0.005. (C) BMP4
exposure for 8 h is sufficient to induce cell death. Neuroblasts were
initially cultured in 10 ng/ml BMP4. The medium was replaced
with control medium after 2–18 h, and viability was assessed at
24 h. p, Differs from control at P 5 0.05; pp, Differs from control at
FIG. 4. RNase protection analysis of Msx-2 and p21 expression in
sympathetic neuroblasts. (A) Note that BMP4 (10 ng/ml) induced
Msx-2 expression after 6 and 12 h of culture. Addition of an Msx-2
antisense oligonucleotide (AS-Msx2) to BMP4-treated cultures at
the time of plating substantially inhibited Msx-2 expression, while
a sense control oligonucleotide (S-Msx2) did not. (B) p21 expression
is induced by BMP4 after 12 h in culture. p21 expression was
greatly diminished in BMP4-treated cultures by p21 antisense
oligonucleotide (AS-p21) whereas a sense control oligonucleotide
(S-p21) had no effect.FIG. 3. Inhibition of proliferation by BMP4 precedes neuroblast
cell death. (A) Time course of BMP4 actions on sympathetic
neuroblast survival. Note that BMP4-induced death is not detect-
able until after 12 h of culture. p, Differs from control at P , 0.01.
B) Time course of BMP4 actions on BrdU incorporation. BrdU was
dded after 30 min of culture for examination at 6 h, at 6 h of
ulture for examination at 12 h, and at 16 h for examination at 24 h.P 5 0.025.
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217BMP4 Regulation of Sympathetic Neuron NumbersEffects of Neurotrophins
Neurotrophins support the survival of sympathetic neu-
rons, and treatment of postmitotic sympathetic neurons
with BMP4 induces expression of the neurotrophin recep-
tor, trkC, and of NT3 (Zhang et al., 1998; Kobayashi et al.,
998). Further, previous studies have shown that BMP
timulation induces neurotrophin dependence in a sympa-
hoadrenal cell line (Song et al., 1998). BMPs therefore
epresent candidate inducers of neurotrophin dependence
uring sympathetic ganglion development, suggesting that
MP4-treated neurons might depend on neurotrophins for
urvival. We therefore tested the ability of neurotrophins to
escue BMP4-treated sympathetic neuroblasts in primary
ulture (Fig. 7). In control medium lacking BMP4 and
eurotrophins, 74% of neuroblasts remained viable at 24 h,
nd addition of the neurotrophins NGF or NT-3 did not
ffect viability. In cultures treated with BMP4 alone, viabil-
ty fell to approximately 35%. However addition of either
GF or NT-3 entirely reversed this decline, resulting in
ver 90% survival in the combined conditions. By contrast,
DNF treatment had no significant effects on BMP-
ediated decreases in viability (data not shown).
The experiments presented in Fig. 3 show that exposure to
MP4 for only 12 h is sufficient to induce cell death, but that
orphologic cell death occurs after this 12-h window. Further,
eurotrophin stimulation is sufficient to prevent BMP4-
nduced cell death. It was unclear, however, whether neuro-
last rescue by neurotrophins requires the continuing pres-
nce of BMP4. We next tested whether neuroblasts
rogrammed to die by BMP4 exposure can be rescued by
FIG. 5. Msx-2 is required for BMP4-induced cell death, but not for
for 24 h in control or BMP4-containing medium. Oligonucleotides
some cultures after 16 h in vitro. (A) Note that addition of M
MP4-induced cell death, while a sense control oligonucleotide
antisense oligonucleotide did not prevent the decrease in cell prol
pp, P , 0.02 from control but does not differ significantly from BMeurotrophin stimulation in the absence of BMP4. Neuro-
Copyright © 2001 by Academic Press. All rightlasts were cultured in control or BMP4-containing medium
or 12 h, then switched to either control medium or NT3-
ontaining medium. Cells cultured in control medium dis-
layed 67% viability and addition of NT3 for the final 12 h of
ulture did not affect viability (Fig. 7B). As expected, BMP4
reatment for the first 12 h of culture reduced viability to 32%.
ddition of NT3 after BMP4 withdrawal reversed this decline,
emonstrating that cells specified to die by BMP4 can be
escued by neurotrophin stimulation in the absence of con-
inuing BMP4 stimulation.
Role of Bax in BMP4-Induced Cell Death
Neurotrophin deprivation of mature neurons induces
apoptosis through a mechanism that depends on the Bcl-2
family member Bax. The previous experiments suggest that
BMP4 stimulation induces neurotrophin dependence in
sympathetic neuroblasts, leading to their death in the
absence of neurotrophins. If so, then BMP4-induced death
should require Bax function. We tested the necessity for Bax
in BMP4 effects by culturing neuroblasts from E14.5 wild-
type (1/1) and Bax deficient (2/2) mice in BMP4 or control
conditions. As shown in Fig. 8, neuroblasts from Bax-
deficient embryos displayed equivalent survival in control
and BMP4-containing medium. Bax is therefore required for
BMP-induced death of sympathetic neuroblasts.
DISCUSSION
The absolute dependence of PNS neurons on trophic
4 anti-proliferative effects. Sympathetic neuroblasts were cultured
added to some cultures at the time of plating. BrdU was added to
antisense oligonucleotide (AS-Msx2) rescued neuroblasts from
x2) had no effect. p, Differs from control at P , 0.01 (B) Msx-2
ion in BMP4-treated cultures. p, Differs from control at P , 0.01;
lone.BMP
were
sx-2
(S-Ms
iferatfactors for survival, together with limited neurotrophin
s of reproduction in any form reserved.
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218 Gomes and Kesslerproduction in target tissues, ensure that final neuron num-
ber matches the size of the target organ. The exact time at
which neurons become dependent on trophic support has
been a matter of debate. Early reports suggested that sym-
pathetic neuroblasts are partly dependent on neurotrophins
for survival while they are still proliferating. Indeed, sur-
vival of E15.5 sympathetic neuroblasts is greater in cultures
FIG. 6. p21 is required for BMP4-induced cell death, but not for
MP4 anti-proliferative effects. Sympathetic neuroblasts were cul-
ured for 24 h in control or BMP4-containing medium. Oligonucle-
tides were added to some cultures at the time of plating. BrdU was
dded to some cultures after 16 h in vitro. (A) Note that addition of
p21 antisense oligonucleotide (AS-p21) rescued neuroblasts from
BMP4-induced cell death, while a sense control oligonucleotide
(S-p21) had no effect. p, Differs from control at P , 0.025. (B) p21
ntisense oligonucleotide did not significantly prevent the decrease
n cell proliferation in BMP4-treated cultures although there was a
rend towards increased proliferation. A p21 sense control oligonu-
leotide had no effect on proliferation. pp, Differs from control at
, 0.02 but does not differ from BMP4 1 AS-p21. ppp, Differs from
control at P , 0.05.that contain NT-3 (DiCicco-Bloom et al., 1993). It is impor-
Copyright © 2001 by Academic Press. All rightant to note, however, that 40–50% of early sympathetic
euroblasts survive and proliferate even when cultured
ithout neurotrophins or other trophic factors (Coughlin
nd Collins, 1985; Birren et al., 1993; DiCicco-Bloom et al.,
1993, 2000; Fig. 1), and in this study 80% of E14 neuroblasts
survived with only insulin present in the medium. These
results stand in contrast to the absolute requirement of
postmitotic sympathetic neurons for neurotrophic stimuli
in culture and in vivo, and suggest that neuroblasts differ
fundamentally from neurons in their trophic factor require-
ments.
FIG. 7. Neurotrophins rescue BMP4-treated neuroblasts from cell
death. (A) NT-3 (25 ng/ml) or NGF (25 ng/ml) were added to control
and BMP4-containing (10 ng/ml) cultures at the time of plating.
Either NT-3 or NGF treatment blocked the BMP4-mediated decline
in neuroblast viability. Note that neuroblast survival in the BMP4
1 NGF and BMP4 1 NT-3 conditions exceeded that in control
medium. p, Differs from control at P , 0.025 (B) Neurotrophin
rescue does not require continuing BMP4 stimulation. Neuroblasts
were initially cultured in control or BMP4-containing (10 ng/ml)
medium. After 12 h, the cultures were washed and the medium
replaced with control or NT3-containing medium. Viability was
assessed 24 h after plating. p, Differs from control at P , 0.01
s of reproduction in any form reserved.
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219BMP4 Regulation of Sympathetic Neuron NumbersThe timing of neurotrophin-dependence has been tested
directly in mice lacking neurotrophin or neurotrophin re-
ceptor genes. One initial report suggested that proliferating
sympathetic neuroblasts of NT-3-deficient mice undergo
apoptosis (ElShamy et al., 1996). Two additional studies of
imilar mice, however, found no cell death among prolifer-
ting neuroblasts (Wyatt et al., 1997; Francis et al., 1999). A
recent, exhaustive examination of mice deficient in both
NT-3 and NGF concluded that sympathetic neuroblast
proliferation, survival, and differentiation are unaffected by
loss of those neurotrophins (Francis et al., 1999). Initial
neuron numbers are unchanged in the knockout mice,
while dramatic neuronal deficits and apoptosis of differen-
tiated neurons are apparent later in development. Deficits
in sympathetic neuron number in SCGs of NT-3 and NGF
knockout mice are not observed until E17.5 (Wyatt et al.,
1997; Francis et al., 1999), a time that corresponds with the
nd of significant proliferation in mouse SCGs (Fagan et al.,
1996). The best available evidence therefore suggests that,
while postmitotic sympathetic neurons depend upon neu-
rotrophins for survival, proliferative sympathetic neuro-
blasts do not. In addition, acquisition of neurotrophin
dependence coincides with the end of neuroblast prolifera-
tion, suggesting that these changes may be governed by a
common mechanism.
What mechanisms govern the loss of proliferative capac-
ity and concomitant acquisition of neurotrophin depen-
dence by sympathetic neuroblasts? It has been suggested
that NT-3 itself may regulate these changes (Verdi and
Anderson, 1994), but examinations of NT-3-deficient mice
do not support that conclusion (Wyatt et al., 1997; Francis
et al., 1999). The results of our present study lead us to
FIG. 8. Bax is required for BMP4-induced cell death. Sympathetic
neuroblasts from wild-type (Bax 1/1) or Bax-deficient (Bax 2/2)
mice were cultured in control or BMP4-containing (10 ng/ml)
medium. BMP4 treatment significantly reduced viability of cells
from wild-type mice but did not significantly diminish survival of
Bax-deficient cells. p, Differs from control at P 5 0.02propose that BMPs, and in particular BMP4, may induce l
Copyright © 2001 by Academic Press. All rightifferentiation of sympathetic neuroblasts into postmitotic,
eurotrophin-dependent neurons in vivo.
Substantial evidence suggests that BMPs regulate other
spects of sympathetic neuron development. BMPs appear
o be essential for the induction of neural crest (Liem et al.,
995), for specification of a neuronal phenotype by neural
rest cells in vitro (Shah et al., 1999), and for the generation
of sympathetic neurons in vivo (Schneider et al., 1999). In
ddition, BMPs regulate neurotrophin receptor expression
Zhang et al., 1998; Kobayashi et al., 1998), neurotransmit-
ter phenotype, and neuropeptide production (Fann and
Patterson, 1994; Ai et al., 1999) in mature sympathetic
neurons. BMP4 is expressed adjacent to embryonic sympa-
thetic ganglia, which themselves express BMP receptors
(Shah et al., 1996; Zhang et al., 1998), indicating the
otential for BMP stimulation of neuroblasts in vivo.
Our results, and those of a recent report by Pisano et al.
2000), show that BMPs inhibit proliferation and survival of
ultured sympathetic neuroblasts. Pisano et al. found that
MP2 treatment reduced proliferation and enhanced death
f E14.5 thoracic sympathetic ganglion cells in culture.
otably, BMPs may also inhibit proliferation and survival
f neocortical ventricular zone cells much as they do
ympathetic neuroblasts. Furuta et al. (1997) ascribe this
ole to several BMPs in the dorsomedial cortex of E10.5
ice, and show that exogenous BMPs reduce proliferation
nd induce apoptosis in explanted cerebral cortices. Fur-
her, BMPs inhibit proliferation and survival of embryonic
eocortical cells in dissociated culture (Mabie et al., 1999).
he parallels between these results and our own are strik-
ng, and suggest that BMPs may serve as general inhibitors
f neurogenesis in both the central and peripheral nervous
ystems. As such, they may counterbalance the mitogenic
timuli thought to promote neuroblast proliferation in
hese regions. Confirmation of this hypothesis will require
isruption of BMP signaling during PNS development in
ivo. While targeted mutations in both the BMP2 and BMP4
enes have been prepared, mice harboring these mutations
o not generally survive past E10 and are not useful for
tudies of neural development (Winnier et al., 1995; Zhang
nd Bradley, 1996). Such knockout experiments are also
omplicated by the potential for redundant function of
MPs, which might allow compensation for loss of only one
MP through increased expression of others. Another prom-
sing approach might utilize protein inhibitors of BMP
unction, which include noggin (Zimmerman et al., 1996),
nd chordin (Piccolo et al., 1996). Our hypothesis predicts
hat inhibition of BMP signaling would result in augmented
euroblast proliferation and increased initial neuron num-
ers.
While neuroblast proliferation in cultures treated with
MP4 is dramatically reduced after 12 and 24 h in culture,
fter 6 h, proliferation is paradoxically increased. There are
everal possible explanations for this observation. Our
stimate of proliferation relies on detection of cells that
ncorporate the nucleotide analog BrdU. In addition to
abeling proliferating cells as they synthesize DNA, BrdU
s of reproduction in any form reserved.
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220 Gomes and Kesslerincorporation is sometimes detected in cells that actively
repair DNA damage (Selden et al., 1993). The initial in-
rease in BrdU incorporation may be due to augmented
NA repair in BMP4-treated cultures. It is also possible
hat BMP stimulation activates both pro-mitotic and anti-
itotic programs in the same cells. In this scenario, the
ro-mitotic program is activated more rapidly and leads to
reater initial proliferation, while the slower anti-mitotic
rogram predominates after 12 h in culture. This possibility
s supported by studies that attributed pro-mitotic effects to
MP-7 (Arkell and Beddington, 1997; Knutsen et al., 1993).
egardless of the cause of this initial, paradoxical rise in
rdU incorporation, the predominant effect of BMP4 on
onger-lived cultures is a drastic reduction of proliferation.
What is the relationship between BMP-induced cell death
nd the inhibition of proliferation observed in SCG neuro-
last cultures? In particular, are these independent effects?
onceptually, BMPs could inhibit proliferation indirectly
y selectively killing the cells that proliferate most rapidly,
y directly exerting an anti-mitotic effect, or both. Our data
uggest that BMPs inhibit proliferation directly indepen-
ent of effects on cell survival. First, in our time course
xperiments, we found that inhibition of proliferation by
MP4 is maximal after 12 h in culture, a time when
MP4-induced cell death is not yet evident. Second, data
rom our antisense inhibition experiments show that cell
illing and reduced proliferation differ in their intracellular
equirements. Specifically, BMP4-induced cell death is
ompletely dependent upon induction of both Msx-2 and
21, while neither gene is required for the anti-proliferative
ffects of BMP-4. Our data show, therefore, that cell death
nd inhibition of proliferation are two distinct processes
ith specific intracellular requirements. Our experiments
urther suggest that BMPs induce neurotrophin dependence
n sympathetic neuroblasts, since BMP4-treated cells sur-
ive only in the presence of neurotrophins.
BMP4-induced cell death of sympathetic neuroblasts de-
ended upon induction of Msx-2 and p21. Msx-2 is a
omeobox-containing gene that is expressed at sites where
ellular proliferation and programmed cell death occur. It
as been implicated as a BMP target gene that is involved in
poptosis of neural crest developing from specific rhom-
omeres (Graham et al., 1994), of chick limb (Zou and
iswander, 1996; Ferrari et al., 1998), of calvarial bone
Rice et al., 1999), and of other tissues (Marazzi et al., 1997).
The direct gene targets that are regulated by Msx-2 in the
apoptotic cascade are not known. P21 is a CDK inhibitor
that is regulated by the tumor suppressor p53 and that is
thought to mediate G1 arrest (Deng et al., 1995). P21 is also
BMP target gene that has been implicated in apoptosis in
he developing tooth enamel knot (Jernvall et al., 1998).
nhibition of either Msx-2 or p21 was sufficient to block
MP-mediated death of sympathetic neuroblasts, suggest-
ng that they may be part of the same apoptotic cascade.
In summary, BMP4 treatment promotes exit of sympa-
hetic neuroblasts from cell cycle, and BMP4-treated neu-
oblasts acquire neurotrophin requirements similar to those
Copyright © 2001 by Academic Press. All rightf sympathetic neurons in vivo. Thus, the BMP effects
bserved in vitro are sufficient to explain the transition
rom proliferative, neurotrophin-independent sympathetic
euroblasts to postmitotic, neurotrophin-dependent neu-
ons.
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